Start Date
January 3, 2022
Primary Completion Date
November 30, 2022
Study Completion Date
November 30, 2022
Angiotensin II
Angiotensin II (Giapreza) is a pharmacologic version of a naturally occurring hormone of the same name, peptide hormone of the renin-angiotensin-aldosterone system (RAAS), that was FDA-approved in 2017 as a vasoconstrictive agent in the treatment of vasodilatory shock.
Vasopressin
Vasopressin (Vasostrict) is a pharmacologic version of a naturally occurring peptide hormone that serves as a vasoconstrictive agent in the treatment of vasodilatory shock.
University of New Mexico Health Sciences Center, Albuquerque
Collaborators (1)
La Jolla Pharmaceutical Company
INDUSTRY
National Center for Advancing Translational Sciences (NCATS)
NIH
University of New Mexico
OTHER